Ownership history in Clearstead Advisors, LLC · 9 quarters on record
This page tracks every 13F SEC filing in which Clearstead Advisors, LLC reported a position in XORTX THERAPEUTICS INC (XRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 277 | — | 0% | 0.00% | $156 | $0.56 |
| 2025 Q3 | UNCHANGED | 277 | — | 0% | 0.00% | $225 | $0.81 |
| 2025 Q2 | UNCHANGED | 277 | — | 0% | 0.00% | $251 | $0.90 |
| 2025 Q1 | UNCHANGED | 277 | — | 0% | 0.00% | $266 | $0.96 |
| 2024 Q4 | UNCHANGED | 277 | — | 0% | 0.00% | $313 | $1.13 |
| 2024 Q3 | UNCHANGED | 277 | — | 0% | 0.00% | $455 | $1.64 |
| 2024 Q2 | UNCHANGED | 277 | — | 0% | 0.00% | $527 | $1.90 |
| 2024 Q1 | UNCHANGED | 277 | — | 0% | 0.00% | $696 | $3.70 |
| 2023 Q4 | INITIATED | 277 | — | — | 0.00% | $640 | — |
As of 2025 Q4 — sorted by position size